Core area “Health, social protection and population policy” Developing local markets for medicinal products

    Africa’s dependence on vaccine and drug imports from abroad has been thrown into sharp focus by the COVID-19 pandemic. The continent needs its own production facilities in order to improve supply. That is why Germany has been supporting the Senegalese government in its efforts to comprehensively develop the country’s pharmaceuticals sector.

    Production of antigen tests at the Institut Pasteur in Dakar, Senegal

    Production of antigen tests at the Institut Pasteur in Dakar, Senegal

    The aim is to set up a value chain for the production and regional marketing of medicinal products and vaccines in cooperation with the private sector. Support is being provided, for instance, to the Institut Pasteur of Dakar Foundation which is currently developing a production facility for COVID-19 and other vaccines. German support will also help set up an independent regulatory authority for the pharmaceuticals industry.

    In order to underline the importance of this matter, it was agreed at the government negotiations in October 2022 that health would be included as a fourth core area of German-Senegalese development cooperation.


    As at: 22/06/2023